Synairgen Management
Management criteria checks 4/4
Synairgen's CEO is Richard Marsden, appointed in Sep 2009, has a tenure of 14.67 years. total yearly compensation is £328.00K, comprised of 94.5% salary and 5.5% bonuses, including company stock and options. directly owns 0.49% of the company’s shares, worth £62.14K. The average tenure of the management team and the board of directors is 3.3 years and 16.4 years respectively.
Key information
Richard Marsden
Chief executive officer
UK£328.0k
Total compensation
| CEO salary percentage | 94.5% |
| CEO tenure | 14.7yrs |
| CEO ownership | 0.5% |
| Management average tenure | 3.3yrs |
| Board average tenure | 16.4yrs |
Recent management updates
Recent updates
Here's Why We're Not Too Worried About Synairgen's (LON:SNG) Cash Burn Situation
Dec 09
Here's Why We're Watching Synairgen's (LON:SNG) Cash Burn Situation
Aug 24Is Synairgen (LON:SNG) In A Good Position To Invest In Growth?
Apr 29Companies Like Synairgen (LON:SNG) Could Be Quite Risky
Dec 27We're A Little Worried About Synairgen's (LON:SNG) Cash Burn Rate
Sep 13Companies Like Synairgen (LON:SNG) Could Be Quite Risky
May 31Here's Why We're Not Too Worried About Synairgen's (LON:SNG) Cash Burn Situation
Feb 06We're Hopeful That Synairgen (LON:SNG) Will Use Its Cash Wisely
Oct 21We're Hopeful That Synairgen (LON:SNG) Will Use Its Cash Wisely
Mar 29How Much Of Synairgen plc (LON:SNG) Do Institutions Own?
Dec 14CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | -UK£10m |
| Mar 31 2023 | n/a | n/a | -UK£14m |
| Dec 31 2022 | UK£328k | UK£310k | -UK£18m |
| Sep 30 2022 | n/a | n/a | -UK£23m |
| Jun 30 2022 | n/a | n/a | -UK£28m |
| Mar 31 2022 | n/a | n/a | -UK£38m |
| Dec 31 2021 | UK£1m | UK£256k | -UK£49m |
| Sep 30 2021 | n/a | n/a | -UK£46m |
| Jun 30 2021 | n/a | n/a | -UK£43m |
| Mar 31 2021 | n/a | n/a | -UK£28m |
| Dec 31 2020 | UK£415k | UK£194k | -UK£14m |
| Sep 30 2020 | n/a | n/a | -UK£10m |
| Jun 30 2020 | n/a | n/a | -UK£6m |
| Mar 31 2020 | n/a | n/a | -UK£5m |
| Dec 31 2019 | UK£289k | UK£190k | -UK£4m |
| Sep 30 2019 | n/a | n/a | -UK£4m |
| Jun 30 2019 | n/a | n/a | -UK£4m |
| Mar 31 2019 | n/a | n/a | -UK£3m |
| Dec 31 2018 | UK£205k | UK£186k | -UK£3m |
| Sep 30 2018 | n/a | n/a | -UK£898k |
| Jun 30 2018 | n/a | n/a | UK£2m |
| Mar 31 2018 | n/a | n/a | UK£2m |
| Dec 31 2017 | UK£336k | UK£182k | UK£2m |
Compensation vs Market: Richard's total compensation ($USD409.79K) is about average for companies of similar size in the UK market ($USD344.28K).
Compensation vs Earnings: Richard's compensation has been consistent with company performance over the past year.
CEO
Richard Marsden (56 yo)
14.7yrs
Tenure
UK£328,000
Compensation
Mr. Richard Marsden has been Chief Executive Officer of Synairgen Research Ltd since September 2009. Mr. Marsden has been Managing Director and Executive Director at Synairgen since June 2004 has been its...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, MD & Executive Director | 14.7yrs | UK£328.00k | 0.49% £ 62.1k | |
| Co-Founder | no data | UK£44.00k | 0.45% £ 56.9k | |
| Chairman of Scientific Advisory Board | 14.7yrs | UK£240.00k | 0.21% £ 26.5k | |
| Co-Founder & Member of Scientific Advisory Board | no data | no data | no data | |
| Co-Founder & Member of Scientific Advisory Board | no data | no data | no data | |
| CFO & Executive Director | less than a year | no data | no data | |
| Chief Regulatory Officer | 2.6yrs | no data | no data | |
| Senior VP & Head of Clinical Operations | 12.4yrs | no data | no data | |
| Senior VP and Head of CMC & Quality | 2.7yrs | no data | no data | |
| Head of Laboratory | 5.1yrs | no data | no data | |
| Chief Medical Officer | less than a year | no data | no data | |
| Company Secretary | 3.3yrs | no data | no data |
3.3yrs
Average Tenure
55yo
Average Age
Experienced Management: SNG's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, MD & Executive Director | 19.9yrs | UK£328.00k | 0.49% £ 62.1k | |
| Co-Founder | 20.9yrs | UK£44.00k | 0.45% £ 56.9k | |
| Chairman of Scientific Advisory Board | 14.7yrs | UK£240.00k | 0.21% £ 26.5k | |
| Co-Founder & Member of Scientific Advisory Board | no data | no data | no data | |
| Co-Founder & Member of Scientific Advisory Board | no data | no data | no data | |
| CFO & Executive Director | less than a year | no data | no data | |
| Non-Executive Chairman | 20.9yrs | UK£84.00k | 0.76% £ 95.5k | |
| Non-Executive Director & Member of Scientific Advisory Board | 18.1yrs | UK£44.00k | 0.16% £ 20.7k | |
| Member of Scientific Advisory Board & Independent Non-Executive Director | 1.7yrs | UK£11.00k | no data | |
| Independent Non-Executive Director | 1.5yrs | UK£4.00k | no data |
16.4yrs
Average Tenure
57yo
Average Age
Experienced Board: SNG's board of directors are seasoned and experienced ( 16.4 years average tenure).